IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 28 filers reported holding IMMUNE DESIGN CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,382,000 | +2.9% | 133,509 | -3.0% | 0.01% | 0.0% |
| Q2 2017 | $1,343,000 | +1765.3% | 137,709 | +1198.0% | 0.01% | – |
| Q1 2017 | $72,000 | +18.0% | 10,609 | -4.5% | 0.00% | – |
| Q4 2016 | $61,000 | -29.1% | 11,109 | -1.8% | 0.00% | – |
| Q3 2016 | $86,000 | +1.2% | 11,309 | +9.0% | 0.00% | – |
| Q2 2016 | $85,000 | -38.4% | 10,378 | -1.9% | 0.00% | -100.0% |
| Q1 2016 | $138,000 | -34.9% | 10,578 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $212,000 | -50.7% | 10,578 | -70.0% | 0.00% | -50.0% |
| Q3 2015 | $430,000 | -43.9% | 35,208 | -5.2% | 0.00% | -33.3% |
| Q2 2015 | $767,000 | +46.9% | 37,128 | +50.0% | 0.00% | +50.0% |
| Q1 2015 | $522,000 | +20.3% | 24,749 | +75.5% | 0.00% | 0.0% |
| Q4 2014 | $434,000 | +104.7% | 14,099 | +17.4% | 0.00% | +100.0% |
| Q3 2014 | $212,000 | – | 12,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,236,394 | $5,626,000 | 8.66% |
| Versant Venture Management, LLC | 2,208,210 | $10,047,356,000 | 3.14% |
| EcoR1 Capital, LLC | 4,437,600 | $20,191,000 | 1.92% |
| BVF INC/IL | 4,158,353 | $18,921,000 | 1.85% |
| Abingworth LLP | 352,300 | $1,621,000 | 0.93% |
| DAFNA Capital Management LLC | 328,500 | $1,495,000 | 0.70% |
| Bain Capital Public Equity Management, LLC | 1,221,368 | $5,557,000 | 0.38% |
| Portolan Capital Management | 444,875 | $2,024,000 | 0.21% |
| Telemetry Investments, L.L.C. | 113,500 | $516,000 | 0.20% |
| C M BIDWELL & ASSOCIATES LTD | 13,055 | $59,000 | 0.06% |